Drug Profile
Bupivacaine liposomal - Taiwan Liposomal Company
Alternative Names: Bupivacaine encapsulated lipososme - Taiwan Liposomal Company; Nanoliposomal bupivacaine - Taiwan Liposomal Company; TLC 198Latest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Taiwan Liposome Company
- Class Analgesics; Anilides; Anti-inflammatories; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Piperidines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaesthesia; Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Anaesthesia in Taiwan (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Taiwan (Parenteral, Injection)
- 21 Jun 2013 Preclinical trials in Anaesthesia and Pain in Taiwan (Parenteral)